CYTEK BIOSCIENCES, INC. Increase (Decrease) in Accounts Payable
CYTEK BIOSCIENCES, INC. (CTKB) reported Increase (Decrease) in Accounts Payable of $2.13 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-05
- CYTEK BIOSCIENCES, INC. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was $1.74M, a 129.25% increase year-over-year.
- CYTEK BIOSCIENCES, INC. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was $390.00K, a 4.88% decline year-over-year.
- CYTEK BIOSCIENCES, INC. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was -$1.31M, a 607.36% decline year-over-year.
- CYTEK BIOSCIENCES, INC. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was $588.00K, a 73.61% decline year-over-year.
- CYTEK BIOSCIENCES, INC. increase (decrease) in accounts payable for fiscal 2025 was $448.00K, a 82.65% decline from fiscal 2024.
- CYTEK BIOSCIENCES, INC. increase (decrease) in accounts payable for fiscal 2024 was $2.58M.
- CYTEK BIOSCIENCES, INC. increase (decrease) in accounts payable for fiscal 2023 was -$1.78M, a 195.81% decline from fiscal 2022.
- CYTEK BIOSCIENCES, INC. increase (decrease) in accounts payable for fiscal 2022 was $1.86M.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month | Increase (Decrease) in Accounts Payable 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $1.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $2.13M 10-Q · filed 2026-08-05 | $821.00K derived: sum of 3 quarters · filed 2026-08-05 | $1.41M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2026-03-31 | $390.00K 10-Q · filed 2026-05-07 | -$919.00K derived: sum of 2 quarters · filed 2026-05-07 | -$331.00K derived: sum of 3 quarters · filed 2026-05-07 | $428.00K derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-12-31 | -$1.31M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$721.00K derived: sum of 2 quarters · filed 2026-02-26 | $38.00K derived: sum of 3 quarters · filed 2026-08-05 | $448.00K 10-K · filed 2026-02-26 | |
| 2025-09-30 | $588.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $1.35M derived: sum of 2 quarters · filed 2026-08-05 | $1.76M 10-Q · filed 2025-11-05 | $2.02M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-06-30 | $759.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $1.17M 10-Q · filed 2026-08-05 | $1.43M derived: sum of 3 quarters · filed 2026-08-05 | $3.65M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-03-31 | $410.00K 10-Q · filed 2026-05-07 | $668.00K derived: sum of 2 quarters · filed 2026-05-07 | $2.90M derived: sum of 3 quarters · filed 2026-05-07 | $2.38M derived: sum of 4 quarters · filed 2026-05-07 | |
| 2024-12-31 | $258.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.49M derived: sum of 2 quarters · filed 2026-02-26 | $1.97M derived: sum of 3 quarters · filed 2026-02-26 | $2.58M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $2.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $1.71M derived: sum of 2 quarters · filed 2025-11-05 | $2.32M 10-Q · filed 2025-11-05 | $530.00K derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-06-30 | -$519.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $96.00K 10-Q · filed 2025-08-06 | -$1.70M derived: sum of 3 quarters · filed 2026-02-26 | $11.00K derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-03-31 | $615.00K 10-Q · filed 2025-05-08 | -$1.18M derived: sum of 2 quarters · filed 2026-02-26 | $530.00K derived: sum of 3 quarters · filed 2026-02-26 | -$1.47M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2023-12-31 | -$1.79M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$85.00K derived: sum of 2 quarters · filed 2026-02-26 | -$2.09M derived: sum of 3 quarters · filed 2026-02-26 | -$1.78M 10-K · filed 2026-02-26 | |
| 2023-09-30 | $1.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$295.00K derived: sum of 2 quarters · filed 2024-11-07 | $10.00K 10-Q · filed 2024-11-07 | -$898.00K derived: sum of 4 quarters · filed 2025-02-28 | |
| 2023-06-30 | -$2.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | -$1.70M 10-Q · filed 2024-08-06 | -$2.61M derived: sum of 3 quarters · filed 2025-02-28 | -$3.51M derived: sum of 4 quarters · filed 2025-02-28 | |
| 2023-03-31 | $305.00K 10-Q · filed 2024-05-08 | -$603.00K derived: sum of 2 quarters · filed 2025-02-28 | -$1.51M derived: sum of 3 quarters · filed 2025-02-28 | -$615.00K derived: sum of 4 quarters · filed 2025-02-28 | |
| 2022-12-31 | -$908.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | -$1.81M derived: sum of 2 quarters · filed 2025-02-28 | -$920.00K derived: sum of 3 quarters · filed 2025-02-28 | $1.86M 10-K · filed 2025-02-28 | |
| 2022-09-30 | -$907.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$12.00K derived: sum of 2 quarters · filed 2023-11-14 | $2.77M 10-Q · filed 2023-11-14 | $2.03M derived: sum of 4 quarters · filed 2024-03-13 | |
| 2022-06-30 | $895.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $3.68M 10-Q · filed 2023-08-08 | $2.94M derived: sum of 3 quarters · filed 2024-03-13 | $3.57M derived: sum of 4 quarters · filed 2024-03-13 | |
| 2022-03-31 | $2.78M 10-Q · filed 2023-05-09 | $2.04M derived: sum of 2 quarters · filed 2024-03-13 | $2.67M derived: sum of 3 quarters · filed 2024-03-13 | $2.41M derived: sum of 4 quarters · filed 2024-03-13 | |
| 2021-12-31 | -$742.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | -$107.00K derived: sum of 2 quarters · filed 2024-03-13 | -$368.00K derived: sum of 3 quarters · filed 2024-03-13 | -$256.00K 10-K · filed 2024-03-13 | |
| 2021-09-30 | $635.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $374.00K derived: sum of 2 quarters · filed 2022-11-09 | $486.00K 10-Q · filed 2022-11-09 | $2.20M derived: sum of 4 quarters · filed 2023-03-01 | |
| 2021-06-30 | -$261.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | -$149.00K 10-Q · filed 2022-08-10 | $1.57M derived: sum of 3 quarters · filed 2023-03-01 | -$44.00K derived: sum of 4 quarters · filed 2023-03-01 | |
| 2021-03-31 | $112.00K 10-Q · filed 2022-05-12 | $1.83M derived: sum of 2 quarters · filed 2023-03-01 | $217.00K derived: sum of 3 quarters · filed 2023-03-01 | ||
| 2020-12-31 | $1.72M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $105.00K derived: sum of 2 quarters · filed 2023-03-01 | $55.00K 10-K · filed 2023-03-01 | -$55.00K 10-K · filed 2022-03-17 | |
| 2020-09-30 | -$1.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$1.66M 10-Q · filed 2021-11-12 | |||
| 2020-06-30 | -$50.00K 10-Q · filed 2021-09-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |